Skip to main content
ADCES24 Main banner
Back

ET02 - Eversense Long-Term CGM: Supporting Patient Choice to Address Traditional CGM Usage Barriers

Friday, August 9, 2024
12:15 PM – 1:00 PM CT
CE/CME Hours: 0.0

CGM continues to revolutionize diabetes care, but for many people with diabetes there are barriers to the usage of traditional short-term CGMs. Therefore, choice matters. Our multidisciplinary panel of experts and a person living with diabetes will discuss the common issues people with diabetes face with traditional CGMs, including disruptions from sensors falling off, false alarms, compression lows, skin irritation and many more.

They will show how offering choice to include Eversense, the only long-term CGM available – and a truly differentiated experience - really matters.

You will also learn about the Eversense Roadmap — including the iCGM designation and pending FDA clearance of a CGM system lasting as long as 365 days.

Sponsored By: Ascensia Diabetes Care